{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,22]],"date-time":"2026-10-22T21:49:33Z","timestamp":1792705773406,"version":"4.5.0"},"reference-count":26,"publisher":"Elsevier BV","issue":"12","license":[{"start":{"date-parts":[[2021,12,1]],"date-time":"2021-12-01T00:00:00Z","timestamp":1638316800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,12,1]],"date-time":"2021-12-01T00:00:00Z","timestamp":1638316800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,12,1]],"date-time":"2021-12-01T00:00:00Z","timestamp":1638316800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2021,12,1]],"date-time":"2021-12-01T00:00:00Z","timestamp":1638316800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2021,12,1]],"date-time":"2021-12-01T00:00:00Z","timestamp":1638316800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2021,12,1]],"date-time":"2021-12-01T00:00:00Z","timestamp":1638316800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2021,12,1]],"date-time":"2021-12-01T00:00:00Z","timestamp":1638316800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Urologic Oncology: Seminars and Original Investigations"],"published-print":{"date-parts":[[2021,12]]},"DOI":"10.1016\/j.urolonc.2021.04.027","type":"journal-article","created":{"date-parts":[[2021,5,29]],"date-time":"2021-05-29T02:11:12Z","timestamp":1622254272000},"page":"833.e9-833.e17","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":21,"title":["The role of 18F-FDG PET\/CT scan compared to CT-scan alone for lymph node staging before radical cystectomy in patients with bladder cancer"],"prefix":"10.1016","volume":"39","author":[{"given":"Mohamad","family":"Moussa","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohamad Abou","family":"Chakra","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wajih","family":"Saad","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Athanasios","family":"Dellis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Athanasios","family":"Papatsoris","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"1","key":"10.1016\/j.urolonc.2021.04.027_bib0001","first-page":"15","article-title":"Epidemiology of bladder cancer","volume":"8","author":"Saginala","year":"2020","journal-title":"Med Sci (Basel)"},{"issue":"7","key":"10.1016\/j.urolonc.2021.04.027_bib0002","doi-asserted-by":"crossref","first-page":"426","DOI":"10.1016\/j.trecan.2019.05.011","article-title":"Treatment options and outcomes in nonmetastatic muscle invasive bladder cancer","volume":"5","author":"Ghandour","year":"2019","journal-title":"Trends Cancer"},{"issue":"11","key":"10.1016\/j.urolonc.2021.04.027_bib0003","doi-asserted-by":"crossref","first-page":"686","DOI":"10.1038\/s41585-018-0066-1","article-title":"Pelvic lymph node dissection during radical cystectomy for muscle-invasive bladder cancer","volume":"15","author":"Perera","year":"2018","journal-title":"Nat Rev Urol"},{"issue":"22","key":"10.1016\/j.urolonc.2021.04.027_bib0004","doi-asserted-by":"crossref","first-page":"2627","DOI":"10.1200\/JCO.2016.67.5033","article-title":"Comparative effectiveness of treatment strategies for bladder cancer with clinical evidence of regional lymph node involvement","volume":"34","author":"Galsky","year":"2016","journal-title":"J Clin Oncol"},{"issue":"2","key":"10.1016\/j.urolonc.2021.04.027_bib0005","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1016\/j.euf.2016.11.005","article-title":"Clinical lymphadenopathy in urothelial cancer: A transatlantic collaboration on performance of cross-sectional imaging and oncologic outcomes in patients treated with radical cystectomy without neoadjuvant chemotherapy","volume":"4","author":"Moschini","year":"2018","journal-title":"Eur Urol Focus"},{"issue":"1","key":"10.1016\/j.urolonc.2021.04.027_bib0006","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1159\/000440889","article-title":"Evaluation of computed tomography for lymph node staging in bladder cancer prior to radical cystectomy","volume":"96","author":"Horn","year":"2016","journal-title":"Urol Int"},{"issue":"4","key":"10.1016\/j.urolonc.2021.04.027_bib0007","doi-asserted-by":"crossref","first-page":"641","DOI":"10.1016\/j.eururo.2009.05.014","article-title":"FDG-PET\/CT for the preoperative lymph node staging of invasive bladder cancer","volume":"57","author":"Swinnen","year":"2010","journal-title":"Eur Urol"},{"issue":"8","key":"10.1016\/j.urolonc.2021.04.027_bib0008","doi-asserted-by":"crossref","first-page":"4286","DOI":"10.1007\/s00330-018-5959-0","article-title":"Integrated analysis of 18F-FDG PET\/CT improves preoperative lymph node staging for patients with invasive bladder cancer","volume":"29","author":"Girard","year":"2019","journal-title":"Eur Radiol"},{"issue":"6","key":"10.1016\/j.urolonc.2021.04.027_bib0009","doi-asserted-by":"crossref","first-page":"964","DOI":"10.1002\/sim.5587","article-title":"A weighted generalized score statistic for comparison of predictive values of diagnostic tests","volume":"32","author":"Kosinski","year":"2013","journal-title":"Stat Med"},{"issue":"1","key":"10.1016\/j.urolonc.2021.04.027_bib0010","doi-asserted-by":"crossref","DOI":"10.2202\/1557-4679.1188","article-title":"Measures to summarize and compare the predictive capacity of markers","volume":"5","author":"Gu","year":"2009","journal-title":"Int J Biostat"},{"issue":"6","key":"10.1016\/j.urolonc.2021.04.027_bib0011","doi-asserted-by":"crossref","first-page":"371","DOI":"10.4111\/kju.2010.51.6.371","article-title":"Role of pelvic lymphadenectomy in the treatment of bladder cancer: a mini review","volume":"51","author":"Ku","year":"2010","journal-title":"Korean J Urol"},{"issue":"6","key":"10.1016\/j.urolonc.2021.04.027_bib0012","doi-asserted-by":"crossref","first-page":"3082","DOI":"10.21037\/tau.2019.06.01","article-title":"The evolving role of lymphadenectomy for bladder cancer: why, when, and how","volume":"9","author":"Packiam","year":"2020","journal-title":"Transl Androl Urol"},{"issue":"5","key":"10.1016\/j.urolonc.2021.04.027_bib0013","doi-asserted-by":"crossref","first-page":"783","DOI":"10.21037\/tau.2018.08.28","article-title":"Evaluation of lymph node status in patients with urothelial carcinoma-still in search of the perfect imaging modality: a systematic review","volume":"7","author":"Fr\u0105czek","year":"2018","journal-title":"Transl Androl Urol"},{"issue":"25","key":"10.1016\/j.urolonc.2021.04.027_bib0014","doi-asserted-by":"crossref","first-page":"3973","DOI":"10.1200\/JCO.2010.28.7052","article-title":"Clinical value of fluorine-18 2-fluoro-2-deoxy-D-glucose positron emission tomography\/computed tomography in bladder cancer","volume":"28","author":"Apolo","year":"2010","journal-title":"J Clin Oncol"},{"issue":"9","key":"10.1016\/j.urolonc.2021.04.027_bib0015","doi-asserted-by":"crossref","first-page":"1229","DOI":"10.1007\/s00345-016-1772-z","article-title":"The diagnostic accuracy of 18F-fluorodeoxyglucose positron emission tomography and computed tomography in staging bladder cancer: a single-institution study and a systematic review with meta-analysis","volume":"34","author":"Soubra","year":"2016","journal-title":"World J Urol"},{"issue":"1","key":"10.1016\/j.urolonc.2021.04.027_bib0016","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1159\/000488200","article-title":"Diagnostic accuracy of F-18 FDG PET\/CT for preoperative lymph node staging in newly diagnosed bladder cancer patients: a systematic review and meta-analysis","volume":"95","author":"Ha","year":"2018","journal-title":"Oncology"},{"issue":"12","key":"10.1016\/j.urolonc.2021.04.027_bib0017","doi-asserted-by":"crossref","first-page":"1412","DOI":"10.1007\/s00259-005-1886-9","article-title":"FDG-PET for preoperative staging of bladder cancer","volume":"32","author":"Drieskens","year":"2005","journal-title":"Eur J Nucl Med Mol Imaging"},{"issue":"26","key":"10.1016\/j.urolonc.2021.04.027_bib0018","doi-asserted-by":"crossref","first-page":"4314","DOI":"10.1200\/JCO.2008.20.6722","article-title":"Prospective study of [18F]fluorodeoxyglucose positron emission tomography\/computed tomography for staging of muscle-invasive bladder carcinoma","volume":"27","author":"Kibel","year":"2009","journal-title":"J Clin Oncol"},{"issue":"5","key":"10.1016\/j.urolonc.2021.04.027_bib0019","doi-asserted-by":"crossref","first-page":"658","DOI":"10.1111\/j.1464-410X.2010.09212.x","article-title":"Evaluation of fluorodeoxyglucose positron-emission tomography with computed tomography for staging of urothelial carcinoma","volume":"106","author":"Lodde","year":"2010","journal-title":"BJU Int"},{"issue":"2","key":"10.1016\/j.urolonc.2021.04.027_bib0020","doi-asserted-by":"crossref","first-page":"122","DOI":"10.3109\/00365599.2010.544672","article-title":"Preoperative lymph-node staging of invasive urothelial bladder cancer with 18F-fluorodeoxyglucose positron emission tomography\/computed axial tomography and magnetic resonance imaging: correlation with histopathology","volume":"45","author":"Jensen","year":"2011","journal-title":"Scand J Urol Nephrol"},{"issue":"3","key":"10.1016\/j.urolonc.2021.04.027_bib0021","doi-asserted-by":"crossref","first-page":"386","DOI":"10.1007\/s00259-012-2294-6","article-title":"Diuretic 18F-FDG PET\/CT imaging for detection and locoregional staging of urinary bladder cancer: prospective evaluation of a novel technique","volume":"40","author":"Nayak","year":"2013","journal-title":"Eur J Nucl Med Mol Imaging"},{"issue":"8","key":"10.1016\/j.urolonc.2021.04.027_bib0022","doi-asserted-by":"crossref","first-page":"788","DOI":"10.1111\/iju.12045","article-title":"18 F-fluorodeoxyglucose positron emission tomography-computed tomography for preoperative lymph node staging in patients undergoing radical cystectomy for bladder cancer: a prospective study","volume":"20","author":"Hitier-Berthault","year":"2013","journal-title":"Int J Urol"},{"issue":"9","key":"10.1016\/j.urolonc.2021.04.027_bib0023","doi-asserted-by":"crossref","first-page":"3150","DOI":"10.1245\/s10434-015-4369-7","article-title":"FDG PET-CT for lymph node staging of bladder cancer: a prospective study of patients with extended pelvic lymphadenectomy","volume":"22","author":"Jeong","year":"2015","journal-title":"Ann Surg Oncol"},{"issue":"3","key":"10.1016\/j.urolonc.2021.04.027_bib0024","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1111\/bju.12608","article-title":"Role of fluorodeoxyglucose positron emission tomography (FDG PET)-computed tomography (CT) in the staging of bladder cancer","volume":"114","author":"Goodfellow","year":"2014","journal-title":"BJU Int"},{"key":"10.1016\/j.urolonc.2021.04.027_bib0025","article-title":"Staging 18F-fluorodeoxyglucose positron emission tomography\/computed tomography changes treatment recommendation in invasive bladder cancer","author":"Voskuilen","year":"2021","journal-title":"Eur Urol Oncol"},{"issue":"1","key":"10.1016\/j.urolonc.2021.04.027_bib0026","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1016\/j.euf.2017.06.005","article-title":"Detection of lymph node metastasis in patients with bladder cancer using maximum standardised uptake value and 18F-fluorodeoxyglucose positron emission tomography\/computed tomography: results from a high-volume centre including long-term follow-up","volume":"5","author":"Vind-Kezunovic","year":"2019","journal-title":"Eur Urol Focus"}],"container-title":["Urologic Oncology: Seminars and Original Investigations"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1078143921001836?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1078143921001836?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,21]],"date-time":"2025-10-21T10:22:35Z","timestamp":1761042155000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1078143921001836"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,12]]},"references-count":26,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2021,12]]}},"alternative-id":["S1078143921001836"],"URL":"https:\/\/doi.org\/10.1016\/j.urolonc.2021.04.027","relation":{},"ISSN":["1078-1439"],"issn-type":[{"value":"1078-1439","type":"print"}],"subject":[],"published":{"date-parts":[[2021,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The role of 18F-FDG PET\/CT scan compared to CT-scan alone for lymph node staging before radical cystectomy in patients with bladder cancer","name":"articletitle","label":"Article Title"},{"value":"Urologic Oncology: Seminars and Original Investigations","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.urolonc.2021.04.027","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}